Accelerating DRUG DISCOVERY for Frontotemporal Degeneration
ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)
Object
Topic: Alzheimer.
Destination: The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate this progress by supporting innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy etc.) drug development programs for FTD through this request for proposals (RFP).
Budget: $150,000-$200,000.
Duration: 1 year
